title: Non-alcoholic fatty liver disease in common endocrine disorders.
abstract: Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease spanning from simple benign steatosis to steatohepatitis with fibrosis and scarring that can eventually lead to cirrhosis. Its prevalence is rising rapidly and is developing into the leading indication for liver transplantation worldwide. Abnormalities in endocrine axes have been associated with NALFD, including hypogonadism, hypothyroidism, GH deficiency and hypercortisolaemia. In some instances, correction of the endocrine defects has been shown to have a beneficial impact. While in patients with type 2 diabetes the association with NAFLD is well established and recognised, there is a more limited appreciation of the condition among common endocrine diseases presenting with hormonal excess or deficiency. In this review, we examine the published data that have suggested a mechanistic link between endocrine abnormalities and NAFLD and summarise the clinical data endorsing these observations.
authors: Centre for Diabetes, Endocrinology and Metabolism, School of Clinical and Experimental Medicine, Institute of Biomedical Research, University of Birmingham, Birmingham B15 2YY, UK.
authors: Jonathan M
authors: JM
authors: Hazlehurst
authors: Jeremy W
authors: JW
authors: Tomlinson
mesh_terms: D003480:Cushing Syndrome / Q000150:complications* / Q000503:physiopathology; D004393:Dwarfism, Pituitary / Q000150:complications* / Q000503:physiopathology; D005234:Fatty Liver / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D007006:Hypogonadism / Q000150:complications* / Q000503:physiopathology; D007037:Hypothyroidism / Q000150:complications* / Q000503:physiopathology; D065626:Non-alcoholic Fatty Liver Disease